Your browser doesn't support javascript.
loading
Risk of Psychiatric Adverse Events Among Montelukast Users.
Sansing-Foster, Veronica; Haug, Nicole; Mosholder, Andrew; Cocoros, Noelle M; Bradley, Marie; Ma, Yong; Pennap, Dinci; Dee, Elizabeth C; Toh, Sengwee; Pestine, Ella; Petrone, Andrew B; Kim, Ivone; Lyons, Jennifer G; Eworuke, Efe.
Afiliação
  • Sansing-Foster V; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, Md.
  • Haug N; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass.
  • Mosholder A; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, Md.
  • Cocoros NM; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass.
  • Bradley M; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, Md.
  • Ma Y; Division of Biometrics, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, Md.
  • Pennap D; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, Md.
  • Dee EC; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass.
  • Toh S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass.
  • Pestine E; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass.
  • Petrone AB; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass.
  • Kim I; Division of Pharmacovigilance, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, Md.
  • Lyons JG; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass.
  • Eworuke E; Division of Epidemiology, US Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, Md. Electronic address: Efe.Eworuke@fda.hhs.gov.
J Allergy Clin Immunol Pract ; 9(1): 385-393.e12, 2021 01.
Article em En | MEDLINE | ID: mdl-32795564
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Asma / Antiasmáticos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Moldávia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Asma / Antiasmáticos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Revista: J Allergy Clin Immunol Pract Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Moldávia